Literature DB >> 23298363

Use of proton pump inhibitors correlates with increased risk of colorectal cancer in Taiwan.

Shih-Wei Lai, Kuan-Fu Liao, Hsueh-Chou Lai, Cheng-Li Lin, Fung-Chang Sung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23298363     DOI： 10.1111/ajco.12054

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN： 1743-7555            Impact factor:   2.601


× No keyword cloud information.
  9 in total

1.  Correlation between proton pump inhibitors and risk of pyogenic liver abscess.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-04-22       Impact factor: 2.953

2.  A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.

Authors:  C Graham; C Orr; C S Bricks; W M Hopman; N Hammad; R Ramjeesingh
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.

Authors:  Li-Nien Chien; Yan-Jiun Huang; Yu-Hsuan Joni Shao; Chen-Jung Chang; Ming-Tsang Chuang; Hung-Yi Chiou; Yun Yen
Journal:  Int J Cancer       Date:  2015-11-20       Impact factor: 7.396

4.  Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.

Authors:  In Cheol Hwang; Jooyoung Chang; Sang Min Park
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

5.  Association between the chronic use of gastric acid suppressants and high-risk colorectal polyps.

Authors:  Yasutoshi Shiratori; Takashi Ikeya; Naoki Ishii; Kazuki Yamamoto; Tetsuro Honda; Kenkei Hasatani; Naohiro Yoshida; Tsutomu Nishida; Tetsuya Sumiyoshi; Shu Kiyotoki; Masahiro Arai; Ryota Niikura
Journal:  JGH Open       Date:  2021-01-29

6.  Proton pump inhibitors affect capecitabine efficacy in patients with stage II-III colorectal cancer: a multicenter retrospective study.

Authors:  Yoshiko Kitazume; Hitoshi Kawazoe; Ryuji Uozumi; Tomoe Yoshizawa; Hirotoshi Iihara; Hironori Fujii; Masaya Takahashi; Takahiro Arai; Yasushi Murachi; Yumiko Sato; Takahiro Mikami; Koji Hashiguchi; Tomoko Yamazaki; Katsuyuki Takahashi; Yukiyoshi Fujita; Yuki Hosokawa; Issei Morozumi; Masami Tsuchiya; Atsushi Yokoyama; Hironobu Hashimoto; Masakazu Yamaguchi
Journal:  Sci Rep       Date:  2022-04-21       Impact factor: 4.996

7.  Association between the Co-administration of Histamine H2 Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis.

Authors:  Tomoko Yamazaki; Ryuji Uozumi; Hitoshi Kawazoe; Yoshiko Kitazume; Hirotoshi Iihara; Hironori Fujii; Masaya Takahashi; Takahiro Arai; Yasushi Murachi; Yumiko Sato; Takahiro Mikami; Koji Hashiguchi; Tomoe Yoshizawa; Katsuyuki Takahashi; Yukiyoshi Fujita; Yuki Hosokawa; Issei Morozumi; Masami Tsuchiya; Atsushi Yokoyama; Hironobu Hashimoto; Tetsuya Furukawa
Journal:  J Cancer       Date:  2022-08-08       Impact factor: 4.478

8.  Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan.

Authors:  Kao-Chi Cheng; Kuan-Fu Liao; Cheng-Li Lin; Shih-Wei Lai
Journal:  Front Pharmacol       Date:  2017-07-19       Impact factor: 5.810

9.  Is the Use of Proton Pump Inhibitors a Predisposing Factor for Pyogenic Liver Abscesses?

Authors:  Ahmed Elfiky; Mira Alsheikh; Jeff Hosry; Anum Aqsa; Ahmad Abou Yassine; Liliane Deeb
Journal:  Gastroenterology Res       Date:  2021-06-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.